Annual Revenue ($)

Orthofix revenue was $406.56 m in FY, 2020

Quarterly Revenue ($)

FY, 2017FY, 2018FY, 2019FY, 2020
Revenue$433.82 m$453.04 m$459.96 m$406.56 m
Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021
Revenue$108.71 m$111.55 m$111.71 m$109.11 m$115.85 m$113.5 m$104.82 m$73.14 m$110.99 m$105.59 m

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

Orthofix revenue breakdown by business segment: 42.9% from Bone Growth Therapies, 20.6% from Spinal Implants, 14.2% from Biologics and 22.3% from Orthofix Extremities

Orthofix revenue breakdown by geographic segment: 78.7% from United States and 21.3% from Other

FY, 2019FY, 2018FY, 2017
BioStim$185.9 m
Extremity Fixation$103.24 m
Spine Fixation$81.96 m
Biologics$65.5 m$59.68 m$62.72 m
Bone Growth Therapies$197.18 m$195.25 m
Spinal Implants$94.54 m$91.66 m
Orthofix Extremities$102.73 m$106.45 m
FY, 2019FY, 2018FY, 2017
Other$47.99 m$50.9 m$52.54 m
United States$361.94 m$355.35 m$345.15 m
Italy$19.56 m$19.33 m$17.06 m
United Kingdom$10.09 m$8.73 m$8.73 m
Brazil$7.69 m$7.12 m$10.36 m
Germany$12.69 m$11.61 m

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu